Evidence map›Paper›PMID 26195173›Full record

Trial reportArthritis care & research2015

Use of Decision Support for Improved Knowledge, Values Clarification, and Informed Choice in Patients With Rheumatoid Arthritis.

Liana Fraenkel, Cynthia K Matzko, Debra E Webb, Brian Oppermann, Peter Charpentier, Ellen Peters, Valerie Reyna, Eric D Newman

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Arthritis care & research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01721200 ("Learning About Biologics"), which is not on this map. Cited by 20 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 4 pooled it
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01721200 nacompletednot on this map

"Learning About Biologics"

TypeinterventionalSponsorGeisinger ClinicRan2012 to 2015Enrolled125ConditionsRheumatoid ArthritisArmsDecision Support Tool, Usual Care
3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 4 syntheses or guidelines pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Decision aids for people facing health treatment or screening decisions.The Cochrane database of systematic reviews · 2024
    Pooled it
  3. Guideline
  4. Pooled it
  5. Article
  6. Observational
  7. Review
  8. Viruses, Vaccines, and COVID-19: Explaining and Improving Risky Decision-making.Journal of applied research in memory and cognition · 2021
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Educating good decisions.Behavioural public policy · 2017
    Article
  17. Observational
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Liana FraenkelYale University, New Haven, Connecticut.
Cynthia K MatzkoGeisinger Medical Center, Danville, Pennsylvania.
Debra E WebbGeisinger Medical Center, Danville, Pennsylvania.
Brian OppermannGeisinger Medical Group, State College, Pennsylvania.
Peter CharpentierYale University, New Haven, Connecticut.
Ellen PetersOhio State University, Columbus.
Valerie ReynaCornell University, Ithaca, New York.
Eric D NewmanGeisinger Medical Center, Danville, Pennsylvania.
Geisinger Medical Center · USYale University · USCornell University · USThe Ohio State University · US

Funding

Yale Study Support Suite (YES3): Dashboard and Web Portal Software Supporting Research Workflow through integrated, customizable REDCap External ModulesP30AG021342 · NIA · YALE UNIVERSITY · PI Albert C Shaw · 2002 to 2026
$37.9M
Improving Decision Making in Patients with Rheumatic DiseaseK24AR060231 · NIAMS · YALE UNIVERSITY · PI FRAENKEL, LIANA · 2011 to 2018
$1.2M
NIAMS NIH HHS AR-060231-01NIAMS NIH HHS K24 AR060231NIA NIH HHS P30 AG021342NIA NIH HHS P30AG021342
6 · The paper itself

Abstract

objectiveTo examine the potential value of a theory-based, interactive decision support tool in clinical practice for patients with rheumatoid arthritis who are candidates for biologic agents.

methodsWe conducted an 8-week, 2-arm, parallel, single-blind pilot trial in which candidates for treatment escalation with a biologic agent were randomized to receive either a link to a web-based tool or usual care. Outcomes included changes in objective knowledge, subjective knowledge, values clarification, and satisfaction with risk communication as well as the proportion of subjects defined as making an informed choice to escalate care at 2 weeks.

resultsA total of 125 subjects were randomized. Significant between-group differences at 2 weeks favoring the intervention group were seen for changes in objective knowledge, subjective knowledge, and values clarification. No significant between-group differences were found in subjects' satisfaction with risk communication. Among those deciding to escalate care, a greater percentage met the criteria for an informed choice at 2 weeks in the intervention group compared to the control group (32% versus 13%; P = 0.02). Improvements in subjective knowledge and values clarification persisted at 8 weeks. There were no between-group differences in objective knowledge at 8 weeks.

conclusionIn this study, use of a decision support tool at the time of decision-making resulted in improved objective and subjective knowledge, as well as values clarity, compared to usual care. Not all improvements were sustained, emphasizing the need to offer educational support should additional escalation of care be required over the course of the illness.

Indexed as

Choice BehaviorDecision Support TechniquesHealth Knowledge, Attitudes, PracticeAdultAgedArthritis, RheumatoidFemaleHumansMaleMiddle AgedPatient ParticipationPilot ProjectsSingle-Blind Method

Identifiers

PMID26195173
PMCPMC4624478
OpenAlexW2129277127

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.